Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Predictors of first-line treatment persistence in a Portuguese cohort of relapsing-remitting multiple sclerosis.
'Non-criteria' neurologic manifestations of antiphospholipid syndrome: A hidden kingdom to be discovered.
The Changing Landscape of Childhood Inflammatory Central Nervous System Disorders.
Peginterferon beta-1a versus other self-injectable disease-modifying therapies in the treatment of relapsing-remitting multiple sclerosis in Scotland: a cost-effectiveness analysis.
Fumarate modulates the immune/inflammatory response and rescues nerve cells and neurological function after stroke in rats.
Recovery from Toxic-Induced Demyelination Does Not Require the NG2 Proteoglycan.
The Differential Diagnosis of Multiple Sclerosis Using Convex Combination of Infinite Kernels.
Leuprolide Acetate Inhibits Spinal Cord Inflammatory Response in Experimental Autoimmune Encephalomyelitis by Suppressing NF-x03BA;B Activation.
Contribution of iron and protein contents from rat brain subcellular fractions to MR phase imaging.
The Effectiveness of Group Cognitive Behavioral Therapy in Treating Obsessive-Compulsive Disorder in Women with Multiple Sclerosis (MS): A randomized double-blind controlled trial.
Preparation of purified perikaryal and synaptosomal mitochondrial fractions from relatively small hypothalamic brain samples.
Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop.
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells.
Epilepsy in multiple sclerosis: The role of temporal lobe damage.
Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis.
Effects of exercise in a relapsing-remitting model of experimental autoimmune encephalomyelitis.
Corrigendum to "Evolution of diagnostic criteria for multiple sclerosis" [Pol. J. Neurol. Neurosurg. 49 (5) (2015) 313-321].
Abnormal functional connectivity and cortical integrity influence dominant hand motor disability in multiple sclerosis: a multimodal analysis.
Lithium improves cell viability in psychosine-treated MO3.13 human oligodendrocyte cell line via autophagy activation.
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination.
Shared and Distinct Patterns of Oligodendroglial Response in α-Synucleinopathies and Tauopathies.
Serum 25-hydroxyvitamin D3 is associated with disease status in patients with neuromyelitis optica spectrum disorders in south China.
Neurorehabilitation: applied neuroplasticity.
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
Intracellular ion signaling influences myelin basic protein synthesis in oligodendrocyte precursor cells.
Pages
« first
‹ previous
…
800
801
802
803
804
805
806
807
808
…
next ›
last »